Previous 10 | Next 10 |
TRACON Pharmaceuticals ([[TCON]] +2.8%) has initiated dosing in Phase 2 ENVASARC trial, evaluating envafolimab for undifferentiated pleomorphic sarcoma or myxofibrosarcoma, type of cancer in soft tissue. Interim data is expected in mid-2021.Primary objective of this 160-subject tria...
SAN DIEGO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
TRACON Pharmaceuticals ([[TCON]] -0.3%) and its corporate partners, Alphamab Oncology and 3D Medicines, have submitted a marketing application seeking approval for envafolimab (KN035) in MSI-H/dMMR cancer to the National Medical Products Administration in China.Envafolimab is a single-domain ...
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
Looking For Top Penny Stocks Today? Penny stocks have been some of the most interesting stocks to watch this week. Most importantly, small cap stocks, in general, have captivated traders more-so than large caps. One of the reasons has to do with a search for volatility after Monday&...
TRACON Pharmaceuticals, Inc. (TCON) Q3 2020 Earnings Conference Call November 10, 2020 4:30 PM ET Company Participants Charles Theuer - President and Chief Executive Officer Scott Brown - Chief Accounting Officer and Head of Finance Conference Call Participants Presentation Operator Good day,...
Tracon (TCON): Q3 GAAP EPS of -$0.38 beats by $0.28.Cash and cash equivalents were $26.5 million at September 30, 2020, compared to $16.4 million at December 31, 2019. We expect our current cash and cash equivalents to fund operations into the first quarter of 2022.Shares +3%.Press Relea...
SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
OTCMKTS Market:
TRACON Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...